respiratory viral infections | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

47,029 results for “respiratory viral infections”

Trials

View all 40480 →

Respiratory Viral Infections in Pediatric Transplantation

2,669 participants · First posted Oct 9, 2014

MxA-Guided Antiviral Treatment in Respiratory Viral Infections

86 participants · First posted Oct 31, 2024

Functional Impact of Acute Respiratory Viral Infections in Older Adults

1,600 participants · First posted Feb 4, 2026

Drugs

View all 974 →

anti-viroporin therapeutics (respiratory viral infections)

samRNA vaccine combination (multi-respiratory viral infections)

SMNH compounds (oral, norovirus infection) (Spring Bank Pharmaceuticals)

Organizations

View all 150 →

Firebrick Pharma Ltd

Frantz Viral Therapeutics, LLC

United States

VIETNAM VIRAL HEPATITIS ALLIANCE

United States

News

View all 5425 →

ENA Respiratory Initiates Phase II Trial of INNA-051 Nasal Spray for Viral Respiratory Infection Prevention

NanoViricides Advances Broad-Spectrum Antiviral NV-387 to Phase II Trials for MPox and Respiratory Infections

NanoViricides' NV-387 Advances to Phase II Clinical Trials for MPox Treatment

Page 1 of 4703